A randomized, controlled, double-blind study of the safety and tolerability of Sandimmun Neoral in stable renal transplant patients. Argentine Multicentre Study Group
Massari, P.U.; Grosso, S.; de Boccardo, G.; Vásquez, M.C.; Schiavelli, R.O.; Sabbatiello, R.R.; Casadei, D.H.; Rial, M.C.; Jost, L.J.; Túrin, M.D.; Agost Carreño C, A.; Maggiora, E.C.; Gadea, M.M.
Transplantation Proceedings 28(6): 3365-3367
1996
ISSN/ISBN: 0041-1345 PMID: 8962310 Document Number: 467741
Document emailed within 1 workday
Related Documents
Tsang, W.K.; Ho, Y.W.; Tong, K.L.; Chan, W.H.; Chan, A. 1996: Safety, tolerability, and pharmacokinetics of Sandimmun Neoral: conversion study in stable renal transplant recipients Transplantation Proceedings 28(3): 1330-1332Johnson, E.M.; Zimmerman, J.; Duderstadt, K.; Chambers, J.; Sorenson, A.L.; Granger, D.K.; Almond, P.S.; Fryer, J.p.; Leventhal, J.R.; Scarola, J.; Matas, A.J.; Canafax, D.M. 1996: A randomized, double-blind, placebo-controlled study of the safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients Transplantation Proceedings 28(2): 987
Taesch, S.; Niese, D.; Mueller, E.A. 1994: Sandimmun neoral, a new oral formulation of cyclosporin a with improved pharmacokinetic characteristics: safety and tolerability in renal transplant patients Transplantation Proceedings 26(6): 3147-3149
Zhao, S.; Wang, F.; Yang, K.; Hao, Y.; Li, G.; Yang, M.; Yang, Z. 2014: Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study Zhonghua Nei Ke Za Zhi 53(6): 455-459
Neumayer, H.H.; Färber, L.; Haller, P.; Kohnen, R.; Maibücher, A.; Schuster, A.; Vollmar, J.; Waiser, J. 1994: Conversion from Sandimmun to Sandimmun Neoral in patients with stable renal allografts: results after 1 month Transplantation Proceedings 26(5): 2944-2948
Grant, D.; Rochon, J.; Levy, G. 1996: Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group Transplantation Proceedings 28(4): 2232-2233
Grino, J.M. 1994: BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation Annals of Internal Medicine 121(5): 345-347
Voisin, C.; Howard, P.; Ansquer, J.C. 1987: Almitrine bismesylate: a long-term placebo-controlled double-blind study in COAD--Vectarion International Multicentre Study Group Bulletin Europeen de Physiopathologie Respiratoire 23 Suppl. 11: 169s-182s
Lebranchu, Y.; Aubert, P.; Bayle, F.; Bedrossian, J.; Berthoux, F.; Bourbigot, B.; Buchler, M.; Chalopin, J.M.; Deteix, P.; Glotz, D.; Huraut De Ligny, B.; Kessler, M.; Lang, P.; Lefrancois, N.; Le Pogamp, P.; Moulin, B.; Mourad, G.; Olmer, M.; Sraer, J.D.; Touchard, G.; Toupance, O.; Wolf, P.; Puget, S. 2000: Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids. M 55002 French Study Group Transplantation Proceedings 32(2): 396-397
Ueberbacher, H.J.; Patyna, W.D.; Krepp, P.; Puespoek, J.; Neuhaus, R.; Hilbich, K.; Bulitta, M.; Rittinghausen, R. 1991: Randomized, double-blind comparison of isosorbide-5-mononitrate and delayed-action nifedipine in patients with stable exertional angina. Multicenter Study Group Schweizerische Medizinische Wochenschrift 121(49): 1836-1840
Herzog, J.L.; Solomon, J.A.; Draelos, Z.; Fleischer, A.; Stough, D.; Wolf, D.I.; Abramovits, W.; Werschler, W.; Green, E.; Duffy, M.; Rothaul, A.; Tansley, R. 2011: A randomized, double-blind, vehicle-controlled crossover study to determine the anti-pruritic efficacy, safety and local dermal tolerability of a topical formulation (srd174 cream) of the long-acting opiod antagonist nalmefene in subjects with atopic dermatitis Journal of Drugs in Dermatology: Jdd 10(8): 853-860
Min, Z.L.; Zhao, M.; Zhu, Y.H.; Qi, J.; Wang, L.M.; Wang, Y.W. 1996: Experience with clinical use of Sandimmun Neoral in renal transplant patients Transplantation Proceedings 28(3): 1356-1357
Antuono, P.G. 1995: Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group Archives of Internal Medicine 155(16): 1766-1772
Mattioli, V.; Calò, A.; Pisoni, G.; Ancona, G.; Zollino, D.; Brunetti, P. 1998: Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. a multicentre, double-blind, randomised, parallel group, placebo-controlled study Minerva Anestesiologica 64(12): 553-561
Liu, Y.-J.; Xiao, W.; Wang, Z.-Z.; Zhao, B.-J.; Zhou, Z.-M.; Jiang, H.-Z.; Jin, Z.; Wei, S.-B.; Wang, Z.; Wang, D.-M.; Xia, Q.-H.; Lin, J.; Wang, Q. 2013: Effects and safety of varying doses of guizhi fuling capsule in patients with primary dysmenorrhea: a multi-center, randomized, double-blind, placebo-controlled clinical study Zhongguo Zhong Yao Za Zhi 38(12): 2019-2022
Webster, G.F.; Leyden, J.J.; Gross, J.A. 2014: Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne Journal of Drugs in Dermatology: Jdd 13(6): 665-670
Savani, N.; Brautaset, N.J.; Reunanen, M.; Szirmai, I.; Ashford, E.A.; Hassani, H.; Saiers, J. 1999: A double-blind placebo-controlled study assessing the efficacy and tolerability of 50 mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group International Journal of Clinical Practice. Suppl 105: 7-15
Parish, L.C.; Parish, J.L.; Routh, H.B.; Avakian, E.; Olayinka, B.; Pappert, E.J.; Plaum, S.; Fleischer, A.B.; Hardas, B. 2011: A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris Journal of Drugs in Dermatology: Jdd 10(10): 1142-1147
Parish, L.C.; Parish, J.L.; Routh, H.B.; Fleischer, A.B.; Avakian, E.V.; Plaum, S.; Hardas, B. 2011: A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis Journal of Drugs in Dermatology: Jdd 10(11): 1282-1288
Mbopi-Keou, F.-X.; Trottier, S.; Omar, R.F.; Nkele, N.N.; Fokoua, S.ér.; Mbu, E.R.; Domingo, M.-C.; Giguère, J.-F.; Piret, J.; Mwatha, A.; Mâsse, B.ît.; Bergeron, M.G. 2010: A randomized, double-blind, placebo-controlled Phase Ii extended safety study of two Invisible Condom formulations in Cameroonian women Contraception 81(1): 79-85